Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL

Alcon Research34 enrolled

Overview

The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Cataracts

Interventions

AcrySof ReSTOR Aspheric IOLDEVICE

Bilateral implantation with the AcrySof ReSTOR Aspheric Intraocular Lens (IOL) for the replacement of cataract in the natural lens of the eye.

Eligibility

Sex: ALLMin age: 50 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Bilateral cataract patients who require natural crystalline lens removal and bilateral Intraocular Lens (IOL) implantation. * 50\~75 years of age * \<1 Diopter of astigmatism preoperatively (before surgery) as measured by Keratometry readings. Exclusion Criteria: * Patients with pre-existing conditions that could skew the results. * Any of conditions before and during surgery specified in the product information.

Locations (1)

Alcon Call Center for Trial Locations

Fort Worth, Texas, United States

Outcomes

Primary Outcomes

Uncorrected and Best Corrected Visual Acuities (Near and Distance)

Measurement of uncorrected (without spectacles or other visual corrective devices) and best-corrected (with spectacles or other visual corrective devices)visual acuity at both near and distance. Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity.

Time frame: 6 Months Following Cataract Surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.